TRAVERE THERAPEUTICS INC. - COMMON STOCK
18.25
22-November-24 15:44:58
15 minutes delayed
Stocks
-0.01
-0.05%
Today's range
18.03 - 18.93
ISIN
N/A
Source
NASDAQ
-
Travere Therapeutics to Present at the 2022 Jefferies Healthcare Conference
02 Jun 2022 15:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Presentations of Abstracts at the 59th ERA Congress
17 May 2022 15:30:00 By Nasdaq GlobeNewswire
-
16 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 May 2022 16:00:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports First Quarter 2022 Financial Results
05 May 2022 15:01:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
03 May 2022 15:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Report First Quarter 2022 Financial Results
28 Apr 2022 15:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Plan for Chief Financial Officer Transition
20 Apr 2022 15:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Apr 2022 16:00:00 By Nasdaq GlobeNewswire
-
06 Apr 2022 15:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Mar 2022 16:00:00 By Nasdaq GlobeNewswire
-
Travere Prices Upsized $275 Million Convertible Senior Notes Offering
08 Mar 2022 20:00:26 By Nasdaq GlobeNewswire
-
Travere Announces Proposed Convertible Senior Notes Offering
08 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the Barclays Global Healthcare Conference
03 Mar 2022 15:30:00 By Nasdaq GlobeNewswire
-
28 Feb 2022 07:00:02 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
24 Feb 2022 15:01:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Feb 2022 16:00:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
10 Feb 2022 15:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09 Feb 2022 15:30:00 By Nasdaq GlobeNewswire